References
- Boustie J, Tomasi S, Grube M. 2011. Bioactive lichen metabolites: alpine habitats as an untapped source. Phytochem Rev. 10:287–307.
- Cornejo A, Salgado F, Caballero J, Vargas R, Simirgiotis M, Areche C. 2016. Secondary metabolites in ramalina terebrata detected by UHPLC/ESI/MS/MS and identification of parietin as tau protein inhibitor. Int J Mol Sci. 17:E1303.
- Cornejo A, Aguilar F, Caballero L, Machuca L, Muñoz P, Caballero J, Perry G, Ardiles A, Areche C. 2017. Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer's disease. J Enzyme Inhib Med Chem. 32:945–953.
- Huneck S, Yoshimura I. 1996. Data of lichen substances. In: Identification of lichen substances. Berlin (Germany): Springer Verlag; p. 125–446.
- Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, Sievers SA, Liu J, Barrio JR, Eisenberg D. 2011. Towards a pharmacophore for amyloid. PLoS Biol. 9:e1001080.
- Mohamed T, Hoang T, Jelokhani-Niaraki M, Rao PP. 2013. Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design. ACS Chem Neurosci. 4:1559–1570.
- Monti MC, Margarucci L, Riccio R, Casapullo A. 2012. Modulation of tau protein fibrillization by oleocanthal. J Nat Prod. 75:1584–1588.
- Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Santamato A, Lozupone M, Capozzo R, Prete C, Pilotto A, Greco A, Logroscino G. 2016. Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy? Expert Opin Pharmacother. 17:457–461.
- Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang Y, Hascher A, Mandelkow EM, Biernat J, Mandelkow E. 2005. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J Biol Chem. 280:3628–3635.
- Shukla V, Joshi G, Rawat MSM. 2010. Lichens as a potential natural source of bioactive compounds: a review. Phytochem Rev. 9:303–314.
- Yamada M, Ono K, Hamaguchi T, Noguchi-Shinohara M. 2015. Natural Phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis. Adv Exp Med Biol. 863:79–94.